For many decades medical science believed that the immune system and metabolism were independent systems. Beginning around 2011 cutting edge studies began detecting instances where one of these systems was interacting with the other system. Since then, this has grown into a new area of science now given the new name, immunometabolism, meaning the interaction of the two systems.
The fledgling company, MyMD and its investigational new drug, MyMD-1 appear to be smack dab in the middle of this new science of immunometabolism by treating immunometabolic disfunction which causes disease and aging. MyMB Pharmaceuticals goes on to say that "MyMD-1 is a novel drug platform that is being developed to treat a broad range of conditions, including autoimmune disease, neurological disease and aging by addressing deregulation of the immunometabolic system".
If I am not misunderstanding this, it sounds groundbreaking and a major breakthrough in the treatment of disease!
